In melanoma, β-catenin signaling upregulates IL-10 secretion, which impairs the capacity of dendritic cells (DCs) to cross-prime CD8+ cytotoxic T cells14, or downregulates CCL4 expression, resulting in DC defective recruitment and T cell exclusion15. This evidence concerns the gene CCL4 and melanoma.